[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351737-105":59,"doc-detail-351737-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","exosomal-lncrnas-hotair-hulc-and-anril-decoding-the-biomarker-landscape-of-sporadic-triple-negative-breast-cancer","Exosomal lncRNAs HOTAIR, HULC, and ANRIL - Decoding the Biomarker Landscape of Sporadic Triple-Negative Breast Cancer","","Triple-negative breast cancer (TNBC) lacks targeted treatment options because it does not express ER/PR or HER2. Exosome-mediated transport of long non-coding RNAs (lncRNAs) influences tumor progression and metastasis by reshaping tumor-associated signaling pathways. This study compared exosomal HOTAIR, NEAT1, MALAT1, AFAP1-AS1, ANRIL, and HULC expression in primary tumor tissue and blood from patients with sporadic TNBC (2021–2025) versus healthy controls. Using Real-Time PCR, HOTAIR, HULC, ANRIL, and AFAP1-AS1 were downregulated, while NEAT1 and MALAT1 were upregulated. Concordant HOTAIR, HULC, and ANRIL expression in tissue and serum supports their biomarker value via exosomal RNA without invasive procedures.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/exosomal-lncrnas-hotair-hulc-and-anril-decoding-the-biomarker-landscape-of-sporadic-triple-negative-breast-cancer/351737/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/exosomal-lncrnas-hotair-hulc-and-anril-decoding-the-biomarker-landscape-of-sporadic-triple-negative-breast-cancer/351737.png","ImageObject",300,407,{"name":92,"@type":93},"McQueen","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-25","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why does triple-negative breast cancer lack targeted treatment options?","Question",{"text":112,"@type":113},"TNBC lacks targeted treatment options due to the absence of ER/PR and HER2 expression, which limits available therapeutic targets.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which exosomal lncRNAs were evaluated in this study?",{"text":117,"@type":113},"The study evaluated exosomal HOTAIR, NEAT1, MALAT1, AFAP1-AS1, ANRIL, and HULC in both primary tumor tissue and blood.",{"name":119,"@type":110,"acceptedAnswer":120},"How were biomarker candidates measured, and what was the main finding?",{"text":121,"@type":113},"Exosomal lncRNA expression was measured using Real-Time PCR. HOTAIR, HULC, and ANRIL showed consistent expression between tissue and serum, supporting their potential as biomarkers using patient serum exosomal RNA without invasive procedures.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351737,1790488140,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},5909890329169,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Article  \nExosomal lncRNAsHOTAIR, HULC, and ANRIL: Decoding the Biomarker Landscape of Sporadic Triple-Negative Breast Cancer  \nHazal Sezginer Guler 1, *, Hakan Gurkan 1, Sinem Yalcintepe 1, Yavuz Atakan Sezer 2, Sernaz Topaloglu 3, Ebru Tastekin 4, Selcuk Korkmaz 5, Daghan Dagdelen 6, Engin Atli 1, Selma Demir 1 and Nermin Tuncbilek 7  \nAcademic Editor: JesúsAdriánLópez  \nReceived: 23 March 2026  \nRevised: 2 May 2026  \nAccepted: 5 May 2026  \nPublished: 12 May 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Departmant of Medical Genetics, Faculty of Medicine, Trakya University, Edirne 22030, Turkey; [hgurkan@trakya.edu.tr](hgurkan@trakya.edu.tr) (H.G.); [sinemyalcintepe@trakya.edu.tr](sinemyalcintepe@trakya.edu.tr) (S.Y.); [enginatli@trakya.edu.tr](enginatli@trakya.edu.tr) (E.A.); [selmaulusal@trakya.edu.tr](selmaulusal@trakya.edu.tr) (S.D.)  \n2 Departmant of General Surgery, Faculty of Medicine, Trakya University, Edirne 22030, Turkey; [atakansezer@trakya.edu.tr](atakansezer@trakya.edu.tr)  \n3 Departmant of Oncology, Faculty of Medicine, Trakya University, Edirne 22030, Turkey; [sernazuzunoglu@trakya.edu.tr](sernazuzunoglu@trakya.edu.tr)  \n4 Departmant of Pathology, Faculty of Medicine, Trakya University, Edirne 22030, Turkey; [ebrutastekin@trakya.edu.tr](ebrutastekin@trakya.edu.tr)  \n5 Departmant of Biostatistics, Faculty of Medicine, Trakya University, Edirne 22030, Turkey; [selcukkorkmaz@trakya.edu.tr](selcukkorkmaz@trakya.edu.tr)  \n6 Department of Plastic Surgery, Faculty of Medicine, Marmara University, Istanbul 34854, Turkey; [daghan.dagdelen@marmara.edu.tr](daghan.dagdelen@marmara.edu.tr)  \n7 Departmant of Radiology, Faculty of Medicine, Trakya University, Edirne 22030, Turkey; [ntuncbilek@trakya.edu.tr](ntuncbilek@trakya.edu.tr)  \n* [Correspondence: hazalsezginer@trakya.edu.tr](Correspondence: hazalsezginer@trakya.edu.tr); Tel.: +90-5435718668  \nAbstract  \nTriple-negative breast cancer (TNBC/18–21%) lacks targeted treatment options due to the lack of ER/PR and HER2 expression. The transport of lncRNAs via exosomes plays a role in tumor progression and metastasis and reshapes tumor-associated signaling pathways. This study aimed to compare the expression of exosomal HOTAIR, NEAT1, MALAT1, AFAP1-AS1, ANRIL, and HULC lncRNAs in primary tumor tissue and blood of patients with sporadic TNBC to evaluate their potential as biomarkers. The patients diagnosed with TNBC between the years 2021 and 2025, 21 of 62 (33.87%) with sporadic breast cancer and thirty healthy controls were included in the study. Primary tumor tissue and peripheral venous blood samples were collected from 21 patients who did not receive neoadjuvant chemotherapy. Expression levels of exosomal lncRNAs (HOTAIR, NEAT1, MALAT1, AFAP1-AS1, ANRIL, and HULC) were determined in both tissues and blood samples from the patient and control groups using Real-Time PCR method. In the patient group, HOTAIR, HULC, ANRIL, and AFAP1_AS1 gene expression was lower (downregulated) in tissue and serum compared to the control group, whereas NEAT1 and MALAT1 were higher (upregulated) . Tissue and serum samples taken from the patient group were found to have statistically consistent expression levels of HOTAIR, HULC, and ANRIL genes. Furthermore, HOTAIR, HULC, and ANRIL serve as biomarkers and can be studied using exosomal RNA samples obtained from patient serum without invasive procedures. Our current study, which has different lncRNA expression profiles, reflects the biological heterogeneity of TNBC and contributes to a better understanding of its subtypes at the molecular level.  \nKeywords: triple-negative breast cancer (TNBC); sporadic breast cancer; long non-coding RNAs (lncRNAs); exosomal RNA; biomarker; prognostic marker  \n1. Introduction  \nBreast cancer is the most common type of cancer worldwide, particularl","cbCaihRXPVpRodZC","https://ap.wps.com/l/cbCaihRXPVpRodZC","pdf",2477750,18,"English","# Introduction\n## Triple-negative breast cancer and biomarker need\n## Biomarkers across sample types\n# Abstract\n## Study aim and patient cohort\n## Methods and expression results\n## Biomarker implications","[{\"question\":\"Why does triple-negative breast cancer lack targeted treatment options?\",\"answer\":\"TNBC lacks targeted treatment options due to the absence of ER/PR and HER2 expression, which limits available therapeutic targets.\"},{\"question\":\"Which exosomal lncRNAs were evaluated in this study?\",\"answer\":\"The study evaluated exosomal HOTAIR, NEAT1, MALAT1, AFAP1-AS1, ANRIL, and HULC in both primary tumor tissue and blood.\"},{\"question\":\"How were biomarker candidates measured, and what was the main finding?\",\"answer\":\"Exosomal lncRNA expression was measured using Real-Time PCR. HOTAIR, HULC, and ANRIL showed consistent expression between tissue and serum, supporting their potential as biomarkers using patient serum exosomal RNA without invasive procedures.\"}]","Exosomal lncRNAs HOTAIR, HULC, and ANRIL - Decoding the Biomarker Landscape of Sporadic Triple-Negative Breast Cancer | PDF",1790095582,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/943e5b79b61a0fcdf9003294ad6962ed.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0ea416a6b243507cebf78798d0da19d8.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eed190282b6cdf7c50663e42903fdbf9.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/970f6949417012ddb1e2015024592fc3.webp",980,1385]